Haematologic neoplasm in survivors of breast cancer
Incidence of myeloid leukaemia and myelodysplasia are higher in women treated for breast cancer
The primary objective of this French study was to evaluate the occurrence and prevalence of secondary haematological types in people living with and beyond breast cancer, but mainly female survivors.
Between 1 July 2006 and 31 December 2015, researchers collected and collated data from a nationwide health data system on 439,704 women diagnosed with breast cancer aged 20-85 years.
The women were followed up until haematologic malignant neoplasm occurrence - such as acute leukaemia, or myelodysplastic or myeloproliferative disorders - death, loss of follow-up or until December 31 2016, whichever came first.
The results show that the incidence of diseases, such as acute myeloid leukaemia (AML) and myelodysplasia (MDS), were markedly higher in women treated for breast cancer than in women in the general population. The
...Want to read more?
Unlock full access to RCNi Plus today
Save over 50% on your first three months:
- Customisable clinical dashboard featuring 200+ topics
- Unlimited online access to all 10 RCNi Journals including Cancer Nursing Practice
- RCNi Learning featuring 180+ RCN accredited learning modules
- NMC-compliant RCNi Portfolio to build evidence for revalidation
- Personalised newsletters tailored to your interests
This article is not available as part of an institutional subscription. Why is this?
